Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock
Background: The urinary thromboxane A2 metabolite 11-dehydro-thromboxane B2 (U-11dhTXB2) has been associated with cardiovascular morbidity and mortality, but remains scarcely explored in acute heart failure (AHF) and cardiogenic shock (CS). We evaluated U-11dhTXB2 profile in AHF and CS patients, as...
Main Author: | |
---|---|
Format: | masterThesis |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10216/142033 |
Country: | Portugal |
Oai: | oai:repositorio-aberto.up.pt:10216/142033 |